Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
Int J Neurosci
    August 2022
  1. KHORRAMI M, Saneipour M, Moridnia A, Shaygannejad V, et al
    Interdependency of NINJ2 gene expression and polymorphism with susceptibility and response to Interferon Beta in patients with Multiple Sclerosis.
    Int J Neurosci. 2022 Aug 1:1-9. doi: 10.1080/00207454.2022.2102979.
    >> Share

    July 2022
  2. MA Y, Wang M, Chen X, Ruan W, et al
    Telomere length and Multiple Sclerosis: A Mendelian Randomization Study.
    Int J Neurosci. 2022 Jul 6:1-9. doi: 10.1080/00207454.2022.2098737.
    >> Share

    June 2022
  3. JALLOULI S, Ghroubi S, Ben Dhia I, Yahia A, et al
    Effect of melatonin intake on postural balance, functional mobility and fall risk in persons with multiple sclerosis: a pilot study.
    Int J Neurosci. 2022 Jun 16:1-19. doi: 10.1080/00207454.2022.2090353.
    >> Share

    May 2022
  4. ZHANG Y, Gu J, Wang X, Li L, et al
    Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis.
    Int J Neurosci. 2022 May 17:1-14. doi: 10.1080/00207454.2022.2042690.
    >> Share

    April 2022
  5. DOSKAS T, Dardiotis E, Vavougios GD, Ntoskas KT, et al
    Stroke risk in multiple sclerosis: a critical appraisal of the literature.
    Int J Neurosci. 2022 Apr 3:1-21. doi: 10.1080/00207454.2022.2056459.
    >> Share

    July 2021
    Understanding Visual-Spatial Perceptual Deficits in Individuals with Multiple Sclerosis: An Analysis of Patient Performance on the Hooper Visual Organization Test and Visual Form Discrimination.
    Int J Neurosci. 2021 Jul 13:1-9. doi: 10.1080/00207454.2021.1954642.
    >> Share

    February 2021
  7. DOSKAS T, Vavougios DG, Karampetsou P, Kormas C, et al
    Neurocognitive Impairment and Social Cognition in Multiple Sclerosis.
    Int J Neurosci. 2021 Feb 2:1-26. doi: 10.1080/00207454.2021.1879066.
    >> Share

    January 2021
  8. YAZDANPANAH M, Jalilian N, Abdollah Zadeh R, Sahraian MA, et al
    Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population.
    Int J Neurosci. 2021 Jan 24:1-6. doi: 10.1080/00207454.2020.1860964.
    >> Share

    October 2020
  9. JANKOVSKA E, Lipcseyova D, Svrdlikova M, Pavelcova M, et al
    Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
    Int J Neurosci. 2020 Oct 15:1-17. doi: 10.1080/00207454.2020.1837801.
    >> Share

  10. BATUM M, Kisabay Ak A, Cetin G, Celebi HBG, et al
    Coincidental Occurance of Episodic Ataxia and Multiple Sclerosis: A Case Report and Review of the Literature.
    Int J Neurosci. 2020 Oct 12:1-7. doi: 10.1080/00207454.2020.1835896.
    >> Share

    September 2020
  11. SURMELI R, Surmeli M, Yalcin AD, Sahin Yilmaz AA, et al
    Multiple Sclerosis Attack Case Presenting with Pseudo-Vestibular Neuritis.
    Int J Neurosci. 2020 Sep 28:1-5. doi: 10.1080/00207454.2020.1829617.
    >> Share

  12. NAJAFI S, Beladi Moghadam N, Saadat P, Noorbakhsh SM, et al
    A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
    Int J Neurosci. 2020 Sep 2:1-12. doi: 10.1080/00207454.2020.1818741.
    >> Share

    August 2020
  13. LABIB DA, Ashmawy I, Elmazny A, Helmy H, et al
    Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients.
    Int J Neurosci. 2020 Aug 26:1-5. doi: 10.1080/00207454.2020.1812601.
    >> Share

  14. ANDALORO A, Russo M, Pastura C, Sessa E, et al
    Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
    Int J Neurosci. 2020 Aug 7:1-13. doi: 10.1080/00207454.2020.1807980.
    >> Share

    June 2020
  15. BRAUN T, Juenemann M, Dornes K, El-Shazly J, et al
    BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
    Int J Neurosci. 2020 Jun 30:1-6. doi: 10.1080/00207454.2020.1784167.
    >> Share

  16. ORTIZ GG, Mireles-Ramirez MA, Pacheco-Moises FP, Ramirez-Jirano LJ, et al
    Are Electrophysiological and Oligodendrocyte Alterations an Element in the Development of Multiple Sclerosis at the Same Time as or Before the Immune Response?
    Int J Neurosci. 2020 Jun 22:1-15. doi: 10.1080/00207454.2020.1786087.
    >> Share

    April 2020
  17. MOUSAVI-SHIRAZI-FARD Z, Mazloom Z, Izadi S, Fararouei M, et al
    The effects of modified anti-inflammatory diet on fatigue, quality of life,and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: A randomized clinical trial.
    Int J Neurosci. 2020 Apr 6:1-12. doi: 10.1080/00207454.2020.1750398.
    >> Share

    February 2020
  18. JAMEBOZORGI K, Rostami D, Pormasoumi H, Taghizadeh E, et al
    Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Int J Neurosci. 2020 Feb 20:1-15. doi: 10.1080/00207454.2020.1732974.
    >> Share

  19. MEUTH SG, Henze T, Essner U, Trompke C, et al
    Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
    Int J Neurosci. 2020 Feb 17:1-15. doi: 10.1080/00207454.2020.1730832.
    >> Share

    December 2019
  20. JAFARINIA M, Sadeghi E, Alsahebfosoul F, Etemadifar M, et al
    Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Int J Neurosci. 2019 Dec 3:1-6. doi: 10.1080/00207454.2019.1694925.
    >> Share

  21. SHAKER OG, Golam RM, Ayoub S, Daker LI, et al
    Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
    Int J Neurosci. 2019 Dec 2:1-7. doi: 10.1080/00207454.2019.1695610.
    >> Share

  22. RAJIZADEH MA, Sheibani V, Bejeshk MA, Mohtashami Borzadaran F, et al
    The effects of high intensity exercise on learning and memory impairments followed by combination of sleep deprivation and demyelination induced by etidium bromide.
    Int J Neurosci. 2019;129:1166-1178.
    >> Share

    November 2019
  23. MORADI M, Gharesouran J, Ghafouri-Fard S, Noroozi R, et al
    Role of NR3C1 and GAS5 genes polymorphisms in Multiple Sclerosis.
    Int J Neurosci. 2019 Nov 14:1-10. doi: 10.1080/00207454.2019.1694019.
    >> Share

    October 2019
    Towards a Comprehensive Etiopathogenetic and Pathophysiological Theory of Multiple Sclerosis.
    Int J Neurosci. 2019 Oct 7:1-41. doi: 10.1080/00207454.2019.1677648.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016